tiprankstipranks
Immunitybio Inc (IBRX)
:IBRX
US Market

ImmunityBio (IBRX) Income Statement

Compare
1,278 Followers

ImmunityBio Income Statement

Last quarter (Q3 2024), ImmunityBio's total revenue was $6.11M, an increase of 7346.34% from the same quarter last year. In Q3, ImmunityBio's net income was $-85.73M. See ImmunityBio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 622.00K$ 240.00K$ 934.00K$ 605.00K$ 2.20M
Gross Profit
$ 622.00K$ -23.95M$ 934.00K$ -8.54M$ -6.81M
Operating Expenses
$ 362.87M$ 350.86M$ 331.21M$ 210.82M$ 158.45M
Depreciation and Amortization
$ 18.51M$ 24.19M$ 19.12M$ 9.15M$ 9.01M
EBITDA
$ -436.18M$ -335.51M$ -315.38M$ -187.93M$ -142.27M
Operating Income
$ -362.25M$ -351.30M$ -330.28M$ -220.88M$ -156.25M
Other Income/Expenses
$ -221.64M$ -65.99M$ -19.56M$ -25.36M$ -3.95M
Pretax Income
$ -583.89M$ -417.29M$ -349.84M$ -226.03M$ -160.26M
Net Income
$ -583.20M$ -417.32M$ -349.85M$ -224.19M$ -160.16M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.15$ -1.04$ -0.90$ -0.59$ -0.42
Diluted EPS
$ -1.15$ -1.04$ -0.90$ -0.59$ -0.42
Weighted Average Shares Outstanding
508.64M 399.90M 389.23M 383.18M 383.18M
Weighted Average Shares Outstanding (Diluted)
508.64M 399.90M 389.23M 383.18M 383.18M
Currency in USD

ImmunityBio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis